104948,0,Admission,O
104948,0,Date,O
104948,0,:,O
104948,0,[,O
104948,0,*,O
104948,0,*,O
104948,0,2154-12-14,O
104948,0,*,O
104948,0,*,O
104948,0,],O
104948,0,Discharge,O
104948,0,Date,O
104948,0,:,O
104948,0,[,O
104948,0,*,O
104948,0,*,O
104948,0,2155-1-4,O
104948,0,*,O
104948,0,*,O
104948,0,],O
104948,0,Date,O
104948,0,of,O
104948,0,Birth,O
104948,0,:,O
104948,0,[,O
104948,0,*,O
104948,0,*,O
104948,0,2074-11-21,O
104948,0,*,O
104948,0,*,O
104948,0,],O
104948,0,Sex,O
104948,0,:,O
104948,0,M,O
104948,0,Service,O
104948,0,:,O
104948,0,MEDICINE,O
104948,0,Allergies,O
104948,0,:,O
104948,0,Sulfa,B-Drug
104948,0,(,I-Drug
104948,0,Sulfonamides,I-Drug
104948,0,),I-Drug
104948,0,Attending,O
104948,0,:,O
104948,0,[,O
104948,0,*,O
104948,0,*,O
104948,0,First,O
104948,0,Name3,O
104948,0,(,O
104948,0,LF,O
104948,0,),O
104948,0,1973,O
104948,0,*,O
104948,0,*,O
104948,0,],O
104948,0,Chief,O
104948,0,Complaint,O
104948,0,:,O
104948,0,Delta,O
104948,0,MS,O
104948,0,",",O
104948,0,respiratory,O
104948,0,distress,O
104948,0,Major,O
104948,0,Surgical,O
104948,0,or,O
104948,0,Invasive,O
104948,0,Procedure,O
104948,0,:,O
104948,0,R,O
104948,0,chest,O
104948,0,tube,O
104948,0,place,O
104948,0,Intubation,O
104948,0,and,O
104948,0,mechanical,O
104948,0,ventilation,O
104948,0,R,O
104948,0,IJ,O
104948,0,central,O
104948,0,line,O
104948,0,placed,O
104948,0,L,O
104948,0,SC,O
104948,0,central,O
104948,0,line,O
104948,0,placed,O
104948,0,PICC,O
104948,0,line,O
104948,0,placed,O
104948,0,History,O
104948,0,of,O
104948,0,Present,O
104948,0,Illness,O
104948,0,:,O
104948,0,80yo,O
104948,0,M,O
104948,0,with,O
104948,1,h/o,O
104948,1,hyperlipidemia,O
104948,1,",",O
104948,1,RA,O
104948,1,",",O
104948,1,new,O
104948,1,diagnosis,O
104948,1,of,O
104948,1,glioblastoma,B-Reason
104948,1,multiforme,I-Reason
104948,1,(,O
104948,1,grade,O
104948,1,4,O
104948,1,),O
104948,1,p/w,O
104948,1,altered,O
104948,1,mental,O
104948,1,status,O
104948,1,and,O
104948,1,respiratory,O
104948,1,distress,O
104948,1,.,O
104948,1,He,O
104948,1,was,O
104948,1,diagnosed,O
104948,1,in,O
104948,1,[,O
104948,1,*,O
104948,1,*,O
104948,1,Month,O
104948,1,(,O
104948,1,only,O
104948,1,),O
104948,1,1096,O
104948,1,*,O
104948,1,*,O
104948,1,],O
104948,1,with,O
104948,1,GBM,O
104948,1,(,O
104948,1,by,O
104948,1,biopsy,O
104948,1,),O
104948,1,in,O
104948,1,the,O
104948,1,setting,O
104948,1,of,O
104948,1,increasing,O
104948,1,confusion,O
104948,1,",",O
104948,1,memory,O
104948,1,loss,O
104948,1,.,O
104948,1,He,O
104948,1,was,O
104948,1,started,O
104948,1,in,O
104948,1,[,O
104948,1,*,O
104948,1,*,O
104948,1,Month,O
104948,1,(,O
104948,1,only,O
104948,1,),O
104948,1,1096,O
104948,1,*,O
104948,1,*,O
104948,1,],O
104948,1,on,O
104948,1,high,B-Reason
104948,1,dose,I-Reason
104948,1,radiation,I-Reason
104948,1,therapy,I-Reason
104948,1,at,O
104948,1,which,O
104948,1,time,O
104948,1,he,O
104948,1,was,O
104948,1,also,O
104948,1,started,O
104948,1,on,O
104948,1,high,O
104948,1,dose,O
104948,1,decadron,B-Drug
104948,1,w/,O
104948,1,q3day,O
104948,1,taper,O
104948,1,(,O
104948,1,most,O
104948,1,recently,O
104948,1,on,O
104948,1,3mg,O
104948,1,),O
104948,1,;,O
104948,1,last,O
104948,1,radiation,O
104948,1,session,O
104948,1,was,O
104948,1,late,O
104948,1,[,O
104948,2,*,O
104948,2,*,O
104948,2,Month,O
104948,2,(,O
104948,2,only,O
104948,2,),O
104948,2,1096,O
104948,2,*,O
104948,2,*,O
104948,2,],O
104948,2,.,O
104948,2,He,O
104948,2,also,O
104948,2,recently,O
104948,2,had,O
104948,2,a,O
104948,2,port,O
104948,2,placed,O
104948,2,through,O
104948,2,which,O
104948,2,he,O
104948,2,was,O
104948,2,receiving,O
104948,2,avastin,B-Drug
104948,2,(,O
104948,2,last,O
104948,2,2,O
104948,2,weeks,O
104948,2,ago,O
104948,2,),O
104948,2,.,O
104948,2,His,O
104948,2,family,O
104948,2,reports,O
104948,2,mildly,O
104948,2,productive,O
104948,2,cough,O
104948,2,(,O
104948,2,cold,O
104948,2,sx,O
104948,2,),O
104948,2,beginning,O
104948,2,approximately,O
104948,2,1,O
104948,2,week,O
104948,2,ago,O
104948,2,;,O
104948,2,he,O
104948,2,had,O
104948,2,a,O
104948,2,CXR,O
104948,2,3-4,O
104948,2,days,O
104948,2,ago,O
104948,2,which,O
104948,2,reportedly,O
104948,2,was,O
104948,2,negative,O
104948,2,for,O
104948,2,pneumonia,B-Reason
104948,2,and,O
104948,2,took,O
104948,2,atovaquone,B-Drug
104948,2,.,O
104948,2,.,O
104948,2,After,O
104948,2,the,O
104948,2,onset,O
104948,2,of,O
104948,2,these,O
104948,2,pulmonary,O
104948,2,symptoms,O
104948,2,",",O
104948,2,he,O
104948,2,later,O
104948,2,developed,O
104948,2,left,B-Reason
104948,2,knee,I-Reason
104948,2,``,I-Reason
104948,2,bursitis,I-Reason
104948,2,``,O
104948,2,last,O
104948,2,week,O
104948,2,for,O
104948,2,which,O
104948,2,he,O
104948,2,received,O
104948,2,injection,O
104948,2,most,O
104948,2,recently,O
104948,2,yesterday,O
104948,2,by,O
104948,2,PCP,O
104948,2,(,O
104948,2,presumably,O
104948,2,steroid,B-Drug
104948,2,injection,O
104948,2,),O
104948,2,.,O
104948,3,He,O
104948,3,had,O
104948,3,largely,O
104948,3,been,O
104948,3,bed,O
104948,3,bound,O
104948,3,over,O
104948,3,the,O
104948,3,last,O
104948,3,few,O
104948,3,days,O
104948,3,[,O
104948,3,*,O
104948,3,*,O
104948,3,1-4,O
104948,3,*,O
104948,3,*,O
104948,3,],O
104948,3,to,O
104948,3,left,O
104948,3,knee,O
104948,3,pain,O
104948,3,.,O
104948,3,Beginning,O
104948,3,this,O
104948,3,morning,O
104948,3,",",O
104948,3,he,O
104948,3,was,O
104948,3,very,O
104948,3,exhausted,O
104948,3,.,O
104948,3,He,O
104948,3,took,O
104948,3,a,O
104948,3,nap,O
104948,3,this,O
104948,3,morning,O
104948,3,and,O
104948,3,when,O
104948,3,he,O
104948,3,awoke,O
104948,3,",",O
104948,3,he,O
104948,3,was,O
104948,3,confused,O
104948,3,",",O
104948,3,somnolent,O
104948,3,",",O
104948,3,lethargic,O
104948,3,.,O
104948,3,His,O
104948,3,wife,O
104948,3,called,O
104948,3,EMS,O
104948,3,and,O
104948,3,he,O
104948,3,was,O
104948,3,transferred,O
104948,3,to,O
104948,3,[,O
104948,3,*,O
104948,3,*,O
104948,3,Hospital1,O
104948,3,18,O
104948,3,*,O
104948,3,*,O
104948,3,],O
104948,3,ED,O
104948,3,.,O
104948,3,En,O
104948,3,route,O
104948,3,to,O
104948,3,the,O
104948,3,ED,O
104948,3,",",O
104948,3,he,O
104948,3,was,O
104948,3,noted,O
104948,3,to,O
104948,3,be,O
104948,3,in,O
104948,3,a.fib,B-Reason
104948,3,with,I-Reason
104948,3,RVR,I-Reason
104948,3,for,O
104948,3,which,O
104948,3,he,O
104948,3,received,O
104948,3,diltiazem,B-Drug
104948,3,.,O
104948,4,.,O
104948,4,In,O
104948,4,the,O
104948,4,ED,O
104948,4,initial,O
104948,4,vitals,O
104948,4,were,O
104948,4,T,O
104948,4,96.7,O
104948,4,HR,O
104948,4,112,O
104948,4,BP,O
104948,4,105/67,O
104948,4,RR,O
104948,4,28,O
104948,4,O2,O
104948,4,sat,O
104948,4,85,O
104948,4,%,O
104948,4,RA,O
104948,4,.,O
104948,4,CXR,O
104948,4,showed,O
104948,4,multifocal,B-Reason
104948,4,PNA,I-Reason
104948,4,at,O
104948,4,RUL,O
104948,4,",",O
104948,4,RLL,O
104948,4,",",O
104948,4,LLL,O
104948,4,.,O
104948,4,He,O
104948,4,was,O
104948,4,placed,O
104948,4,on,O
104948,4,NRB,O
104948,4,and,O
104948,4,shortly,O
104948,4,thereafter,O
104948,4,O2,O
104948,4,sats,O
104948,4,again,O
104948,4,dropped,O
104948,4,to,O
104948,4,the,O
104948,4,80s,O
104948,4,",",O
104948,4,thus,O
104948,4,he,O
104948,4,was,O
104948,4,intubated,O
104948,4,4:30,O
104948,4,pm,O
104948,4,.,O
104948,4,Blood,O
104948,4,cultures,O
104948,4,were,O
104948,4,drawn,O
104948,4,and,O
104948,4,he,O
104948,4,received,O
104948,4,levofloxacin,B-Drug
104948,4,750g,O
104948,4,IV,O
104948,4,x1,O
104948,4,",",O
104948,4,vancomycin,B-Drug
104948,4,1g,O
104948,4,IV,O
104948,4,x1,O
104948,4,",",O
104948,4,ceftriaxone,B-Drug
104948,4,1g,O
104948,4,IV,O
104948,4,x1,O
104948,4,",",O
104948,4,and,O
104948,4,azithromycin,B-Drug
104948,4,500mg,O
104948,4,x1,O
104948,4,.,O
104948,5,He,O
104948,5,also,O
104948,5,received,O
104948,5,10mg,O
104948,5,IV,O
104948,5,decadron,B-Drug
104948,5,.,O
104948,5,He,O
104948,5,was,O
104948,5,initially,O
104948,5,normotensive,O
104948,5,",",O
104948,5,but,O
104948,5,dropped,B-Reason
104948,5,pressure,I-Reason
104948,5,at,O
104948,5,6:30,O
104948,5,pm,O
104948,5,into,O
104948,5,70s,O
104948,5,requiring,O
104948,5,initiation,O
104948,5,of,O
104948,5,phenylephrine,B-Drug
104948,5,gtt,O
104948,5,.,O
104948,5,Over,O
104948,5,his,O
104948,5,entire,O
104948,5,ED,O
104948,5,course,O
104948,5,",",O
104948,5,received,O
104948,5,total,O
104948,5,5L,O
104948,5,NS,B-Drug
104948,5,.,O
104948,5,.,O
104948,5,Head,O
104948,5,CT,O
104948,5,demonstrated,O
104948,5,``,O
104948,5,no,O
104948,5,new,O
104948,5,findings,O
104948,5,'',O
104948,5,and,O
104948,5,was,O
104948,5,reportedly,O
104948,5,reviewed,O
104948,5,by,O
104948,5,[,O
104948,5,*,O
104948,5,*,O
104948,5,Hospital1,O
104948,5,18,O
104948,5,*,O
104948,5,*,O
104948,5,],O
104948,5,neurosurgery,O
104948,5,however,O
104948,5,there,O
104948,5,is,O
104948,5,no,O
104948,5,note,O
104948,5,in,O
104948,5,chart/OMR,O
104948,5,.,O
104948,5,Additionally,O
104948,5,he,O
104948,5,was,O
104948,5,seen,O
104948,5,by,O
104948,5,his,O
104948,5,neurologist,O
104948,5,who,O
104948,5,follows,O
104948,5,him,O
104948,5,at,O
104948,5,[,O
104948,5,*,O
104948,5,*,O
104948,5,Hospital1,O
104948,5,2025,O
104948,5,*,O
104948,5,*,O
104948,5,],O
104948,5,",",O
104948,5,however,O
104948,5,there,O
104948,5,is,O
104948,5,no,O
104948,5,documentation,O
104948,5,of,O
104948,5,this,O
104948,5,.,O
104948,6,Past,O
104948,6,Medical,O
104948,6,History,O
104948,6,:,O
104948,6,#,O
104948,6,Grade,O
104948,6,4,O
104948,6,glioblastoma,B-Reason
104948,6,multiforme,I-Reason
104948,6,left,O
104948,6,temporal,O
104948,6,lobe,O
104948,6,;,O
104948,6,s/p,O
104948,6,high,B-Reason
104948,6,dose,I-Reason
104948,6,radiotherapy,I-Reason
104948,6,",",O
104948,6,previously,O
104948,6,on,O
104948,6,high,O
104948,6,dose,O
104948,6,steroids,B-Drug
104948,6,",",O
104948,6,recently,O
104948,6,tapered,O
104948,6,.,O
104948,6,Recently,O
104948,6,placed,O
104948,6,Portacath,O
104948,6,with,O
104948,6,steristrips,O
104948,6,still,O
104948,6,present,O
104948,6,.,O
104948,6,#,O
104948,6,Rheumatoid,B-Reason
104948,6,arthritis,I-Reason
104948,6,;,O
104948,6,on,O
104948,6,remicade,B-Drug
104948,6,until,O
104948,6,recently,O
104948,6,#,O
104948,6,L,O
104948,6,knee,O
104948,6,bursitis,O
104948,6,#,O
104948,6,Hyperlipidemia,O
104948,6,Social,O
104948,6,History,O
104948,6,:,O
104948,6,Lives,O
104948,6,at,O
104948,6,home,O
104948,6,with,O
104948,6,wife,O
104948,6,.,O
104948,6,[,O
104948,6,*,O
104948,6,*,O
104948,6,Name,O
104948,6,(,O
104948,6,NI,O
104948,6,),O
104948,6,*,O
104948,6,*,O
104948,6,],O
104948,6,and,O
104948,6,daughter-in-law,O
104948,6,(,O
104948,6,who,O
104948,6,is,O
104948,6,[,O
104948,6,*,O
104948,6,*,O
104948,6,Name8,O
104948,6,(,O
104948,6,MD,O
104948,6,),O
104948,6,*,O
104948,6,*,O
104948,6,],O
104948,6,MD,O
104948,6,),O
104948,6,live,O
104948,6,locally,O
104948,6,.,O
104948,7,Smoking,O
104948,7,",",O
104948,7,Etoh,O
104948,7,history,O
104948,7,unknown,O
104948,7,.,O
104948,7,Family,O
104948,7,History,O
104948,7,:,O
104948,7,nc,O
104948,7,Physical,O
104948,7,Exam,O
104948,7,:,O
104948,7,S,O
104948,7,:,O
104948,7,Temp,O
104948,7,:,O
104948,7,97.2,O
104948,7,BP,O
104948,7,:,O
104948,7,99/69,O
104948,7,HR,O
104948,7,:,O
104948,7,138,O
104948,7,a.,O
104948,7,fib,O
104948,7,RR,O
104948,7,:,O
104948,7,22,O
104948,7,O2sat,O
104948,7,92,O
104948,7,%,O
104948,7,AC,O
104948,7,500/19,O
104948,7,PEEP,O
104948,7,14,O
104948,7,FiO2,O
104948,7,1.0,O
104948,7,GEN,O
104948,7,:,O
104948,7,Intubated,O
104948,7,",",O
104948,7,unresponsive,O
104948,7,on,O
104948,7,minimal,O
104948,7,sedation,O
104948,7,HEENT,O
104948,7,:,O
104948,7,Pupils,O
104948,7,pinpoint,O
104948,7,",",O
104948,7,symmetric,O
104948,7,",",O
104948,7,unresponsive,O
104948,7,to,O
104948,7,light,O
104948,7,",",O
104948,7,scleral,O
104948,7,mildy,O
104948,7,icteric,O
104948,7,",",O
104948,7,dry,O
104948,7,MM,O
104948,7,",",O
104948,7,Multiple,O
104948,7,pinpoint,O
104948,7,white,O
104948,7,plaques,O
104948,7,on,O
104948,7,roof,O
104948,7,of,O
104948,7,mouth,O
104948,7,NECK,O
104948,7,:,O
104948,7,no,O
104948,7,supraclavicular,O
104948,7,or,O
104948,7,cervical,O
104948,7,lymphadenopathy,O
104948,7,",",O
104948,7,no,O
104948,7,jvd,O
104948,7,",",O
104948,7,no,O
104948,7,carotid,O
104948,7,bruits,O
104948,7,",",O
104948,7,no,O
104948,7,thyromegaly,O
104948,7,or,O
104948,7,thyroid,O
104948,7,nodules,O
104948,7,CHEST,O
104948,7,:,O
104948,7,Portacath,O
104948,7,site,O
104948,7,right,O
104948,7,anterior,O
104948,7,chest,O
104948,7,with,O
104948,8,steri,O
104948,8,strips,O
104948,8,in,O
104948,8,place,O
104948,8,",",O
104948,8,mildly,O
104948,8,erythematous,O
104948,8,",",O
104948,8,no,O
104948,8,significant,O
104948,8,increase,O
104948,8,warmth/induration/fluctuance,O
104948,8,RESP,O
104948,8,:,O
104948,8,Clear,O
104948,8,anteriorly,O
104948,8,",",O
104948,8,decrease,O
104948,8,BS,O
104948,8,right,O
104948,8,laterally,O
104948,8,",",O
104948,8,no,O
104948,8,wheezing/rales,O
104948,8,CV,O
104948,8,:,O
104948,8,irreg,O
104948,8,irreg,O
104948,8,",",O
104948,8,no,O
104948,8,mrg,O
104948,8,appreciated,O
104948,8,ABD,O
104948,8,:,O
104948,8,nd,O
104948,8,",",O
104948,8,+b/s,O
104948,8,",",O
104948,8,soft,O
104948,8,",",O
104948,8,nt,O
104948,8,",",O
104948,8,no,O
104948,8,masses,O
104948,8,or,O
104948,8,hepatosplenomegaly,O
104948,8,EXT,O
104948,8,:,O
104948,8,1+,O
104948,8,pedal,O
104948,8,edema,O
104948,8,b/l,O
104948,8,",",O
104948,8,right,O
104948,8,foot,O
104948,8,cooler,O
104948,8,than,O
104948,8,left,O
104948,8,1+,O
104948,8,DP,O
104948,8,on,O
104948,8,right,O
104948,8,",",O
104948,8,2+,O
104948,8,DP,O
104948,8,on,O
104948,8,left,O
104948,8,",",O
104948,8,palpable,O
104948,8,PT,O
104948,8,pulses,O
104948,8,b/l,O
104948,8,",",O
104948,8,left,O
104948,8,knee,O
104948,8,with,O
104948,8,small,O
104948,8,effusion,O
104948,8,",",O
104948,8,increased,O
104948,8,warmth,O
104948,8,without,O
104948,8,significant,O
104948,8,increased,O
104948,8,erythema,O
104948,8,SKIN,O
104948,8,:,O
104948,8,appears,O
104948,8,mildly,O
104948,8,jaundiced,O
104948,8,NEURO,O
104948,8,:,O
104948,8,Downgoing,O
104948,8,toes,O
104948,8,b/l,O
104948,8,.,O
104948,9,DTRs,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,Name,O
104948,9,(,O
104948,9,NI,O
104948,9,),O
104948,9,20772,O
104948,9,*,O
104948,9,*,O
104948,9,],O
104948,9,throughout,O
104948,9,including,O
104948,9,biceps,O
104948,9,",",O
104948,9,patellar,O
104948,9,",",O
104948,9,achilles,O
104948,9,.,O
104948,9,Pertinent,O
104948,9,Results,O
104948,9,:,O
104948,9,ADMISSION,O
104948,9,LABS,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,2154-12-14,O
104948,9,*,O
104948,9,*,O
104948,9,],O
104948,9,04:45PM,O
104948,9,BLOOD,O
104948,9,WBC-6.0,O
104948,9,RBC-3.78,O
104948,9,*,O
104948,9,Hgb-11.7,O
104948,9,*,O
104948,9,Hct-34.3,O
104948,9,*,O
104948,9,MCV-91,O
104948,9,MCH-31.0,O
104948,9,MCHC-34.1,O
104948,9,RDW-13.6,O
104948,9,Plt,O
104948,9,Ct-74,O
104948,9,*,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,2154-12-14,O
104948,9,*,O
104948,9,*,O
104948,9,],O
104948,9,04:45PM,O
104948,9,BLOOD,O
104948,9,Neuts-80,O
104948,9,*,O
104948,9,Bands-6,O
104948,9,*,O
104948,9,Lymphs-9,O
104948,9,*,O
104948,9,Monos-3,O
104948,9,Eos-0,O
104948,9,Baso-0,O
104948,9,Atyps-0,O
104948,9,Metas-2,O
104948,9,*,O
104948,9,Myelos-0,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,2154-12-14,O
104948,9,*,O
104948,9,*,O
104948,9,],O
104948,9,04:45PM,O
104948,9,BLOOD,O
104948,9,Hypochr-NORMAL,O
104948,9,Anisocy-NORMAL,O
104948,9,Poiklo-NORMAL,O
104948,9,Macrocy-NORMAL,O
104948,9,Microcy-NORMAL,O
104948,9,Polychr-NORMAL,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,2155-1-2,O
104948,9,*,O
104948,9,*,O
104948,9,],O
104948,9,02:38AM,O
104948,9,BLOOD,O
104948,9,Plt,O
104948,9,Ct-179,O
104948,9,[,O
104948,9,*,O
104948,9,*,O
104948,9,2155-1-2,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,02:38AM,O
104948,10,BLOOD,O
104948,10,PT-14.6,O
104948,10,*,O
104948,10,PTT-35.5,O
104948,10,*,O
104948,10,INR,O
104948,10,(,O
104948,10,PT,O
104948,10,),O
104948,10,-1.3,O
104948,10,*,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,PT-13.3,O
104948,10,PTT-31.5,O
104948,10,INR,O
104948,10,(,O
104948,10,PT,O
104948,10,),O
104948,10,-1.1,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,Plt,O
104948,10,Smr-VERY,O
104948,10,LOW,O
104948,10,Plt,O
104948,10,Ct-74,O
104948,10,*,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,Glucose-98,O
104948,10,UreaN-44,O
104948,10,*,O
104948,10,Creat-1.1,O
104948,10,Na-138,O
104948,10,K-5.3,O
104948,10,*,O
104948,10,Cl-105,O
104948,10,HCO3-23,O
104948,10,AnGap-15,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,CK,O
104948,10,(,O
104948,10,CPK,O
104948,10,),O
104948,10,-52,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,CK-MB-NotDone,O
104948,10,[,O
104948,10,*,O
104948,10,*,O
104948,10,2154-12-14,O
104948,10,*,O
104948,10,*,O
104948,10,],O
104948,10,04:45PM,O
104948,10,BLOOD,O
104948,10,Calcium-8.0,O
104948,10,*,O
104948,11,Phos-3.7,O
104948,11,Mg-2.7,O
104948,11,*,O
104948,11,UricAcd-3.4,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-14,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,10:47PM,O
104948,11,BLOOD,O
104948,11,calTIBC-146,O
104948,11,*,O
104948,11,VitB12-1418,O
104948,11,*,O
104948,11,Folate-3.5,O
104948,11,Ferritn-1409,O
104948,11,*,O
104948,11,TRF-112,O
104948,11,*,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-14,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,10:47PM,O
104948,11,BLOOD,O
104948,11,TSH-0.69,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-15,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,06:26AM,O
104948,11,BLOOD,O
104948,11,Cortsol-26.9,O
104948,11,*,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-14,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,06:50PM,O
104948,11,BLOOD,O
104948,11,Type-ART,O
104948,11,pO2-60,O
104948,11,*,O
104948,11,pCO2-50,O
104948,11,*,O
104948,11,pH-7.30,O
104948,11,*,O
104948,11,calTCO2-26,O
104948,11,Base,O
104948,11,XS,O
104948,11,--,O
104948,11,1,O
104948,11,Intubat-INTUBATED,O
104948,11,Vent-CONTROLLED,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-14,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,07:15PM,O
104948,11,BLOOD,O
104948,11,Lactate-2.2,O
104948,11,*,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-15,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,12:25AM,O
104948,11,BLOOD,O
104948,11,O2,O
104948,11,Sat-98,O
104948,11,[,O
104948,11,*,O
104948,11,*,O
104948,11,2154-12-15,O
104948,11,*,O
104948,11,*,O
104948,11,],O
104948,11,12:25AM,O
104948,11,BLOOD,O
104948,11,freeCa-1.10,O
104948,11,*,O
104948,11,Brief,O
104948,12,Hospital,O
104948,12,Course,O
104948,12,:,O
104948,12,Note,O
104948,12,:,O
104948,12,the,O
104948,12,majority,O
104948,12,of,O
104948,12,this,O
104948,12,hospital,O
104948,12,course,O
104948,12,refers,O
104948,12,to,O
104948,12,the,O
104948,12,patient,O
104948,12,'s,O
104948,12,ICU,O
104948,12,course,O
104948,12,.,O
104948,12,He,O
104948,12,was,O
104948,12,on,O
104948,12,the,O
104948,12,medical,O
104948,12,floor,O
104948,12,for,O
104948,12,16,O
104948,12,hours,O
104948,12,prior,O
104948,12,to,O
104948,12,discharge,O
104948,12,and,O
104948,12,was,O
104948,12,stable,O
104948,12,during,O
104948,12,this,O
104948,12,time,O
104948,12,.,O
104948,12,.,O
104948,12,#,O
104948,12,Septic,O
104948,12,Shock,O
104948,12,:,O
104948,12,Met,O
104948,12,criteria,O
104948,12,for,O
104948,12,septic,O
104948,12,shock,O
104948,12,.,O
104948,12,On,O
104948,12,presentation,O
104948,12,had,O
104948,12,clear,O
104948,12,pulmonary,O
104948,12,source,O
104948,12,of,O
104948,12,infection,O
104948,12,.,O
104948,12,Initial,O
104948,12,sputums,O
104948,12,grew,O
104948,12,out,O
104948,12,pneumococci,O
104948,12,.,O
104948,12,Patient,O
104948,12,relatively,O
104948,12,immunocompromised,B-ADE
104948,12,due,O
104948,12,both,O
104948,12,to,O
104948,12,cancer,O
104948,12,diagnosis,O
104948,12,and,O
104948,12,chronic,O
104948,12,steroid,B-Drug
104948,12,use,O
104948,12,secondary,O
104948,12,to,O
104948,12,brain,B-Reason
104948,12,tumor,I-Reason
104948,12,.,O
104948,13,On,O
104948,13,admission,O
104948,13,patient,O
104948,13,had,O
104948,13,central,O
104948,13,line,O
104948,13,placed,O
104948,13,",",O
104948,13,CVPs,O
104948,13,maintained,O
104948,13,[,O
104948,13,*,O
104948,13,*,O
104948,13,7-15,O
104948,13,*,O
104948,13,*,O
104948,13,],O
104948,13,.,O
104948,13,Patient,O
104948,13,needed,O
104948,13,pressors,B-Drug
104948,13,to,O
104948,13,maintain,B-Reason
104948,13,BP,I-Reason
104948,13,initially,O
104948,13,.,O
104948,13,On,O
104948,13,levophed,B-Drug
104948,13,",",O
104948,13,but,O
104948,13,developed,O
104948,13,some,O
104948,13,tachyarrhythmnias,B-ADE
104948,13,(,I-ADE
104948,13,Afib,I-ADE
104948,13,with,I-ADE
104948,13,RVR,I-ADE
104948,13,),I-ADE
104948,13,so,O
104948,13,was,O
104948,13,switched,O
104948,13,to,O
104948,13,neo,B-Drug
104948,13,.,O
104948,13,Initially,O
104948,13,covered,O
104948,13,with,O
104948,13,Zosyn,B-Drug
104948,13,",",O
104948,13,levoflox,B-Drug
104948,13,and,O
104948,13,vanco,B-Drug
104948,13,.,O
104948,13,Patient,O
104948,13,was,O
104948,13,continued,O
104948,13,on,O
104948,13,atovaquone,B-Drug
104948,13,for,O
104948,13,PCP,B-Reason
104948,13,[,O
104948,13,*,O
104948,13,*,O
104948,13,Name,O
104948,13,Initial,O
104948,13,(,O
104948,13,PRE,O
104948,13,),O
104948,13,6187,O
104948,13,*,O
104948,13,*,O
104948,13,],O
104948,13,.,O
104948,13,Patient,O
104948,13,was,O
104948,13,also,O
104948,13,intubated,O
104948,13,on,O
104948,13,presentation,O
104948,13,",",O
104948,13,and,O
104948,13,maintained,O
104948,13,on,O
104948,13,AC,O
104948,13,.,O
104948,14,Patient,O
104948,14,had,O
104948,14,EKGs,O
104948,14,without,O
104948,14,signs,O
104948,14,of,O
104948,14,ischemia,O
104948,14,",",O
104948,14,and,O
104948,14,multiple,O
104948,14,sets,O
104948,14,of,O
104948,14,normal,O
104948,14,cardiac,O
104948,14,enzymes,O
104948,14,.,O
104948,14,Pressors,O
104948,14,were,O
104948,14,largely,O
104948,14,weaned,O
104948,14,by,O
104948,14,HD,O
104948,14,#,O
104948,14,3,O
104948,14,.,O
104948,14,He,O
104948,14,did,O
104948,14,rarely,O
104948,14,require,O
104948,14,brief,O
104948,14,periods,O
104948,14,of,O
104948,14,neosynepherine,B-Drug
104948,14,",",O
104948,14,due,O
104948,14,to,O
104948,14,too-rapid,B-Reason
104948,14,diuresis,I-Reason
104948,14,.,O
104948,14,The,O
104948,14,patient,O
104948,14,had,O
104948,14,a,O
104948,14,normal,O
104948,14,cortisol,O
104948,14,stim,O
104948,14,test,O
104948,14,.,O
104948,14,Historically,O
104948,14,",",O
104948,14,it,O
104948,14,was,O
104948,14,noted,O
104948,14,that,O
104948,14,the,O
104948,14,patient,O
104948,14,had,O
104948,14,a,O
104948,14,red,O
104948,14,left,O
104948,14,knee,O
104948,14,a,O
104948,14,few,O
104948,14,days,O
104948,14,prior,O
104948,14,to,O
104948,14,admission,O
104948,14,.,O
104948,14,This,O
104948,14,knee,O
104948,14,was,O
104948,14,tapped,O
104948,14,by,O
104948,14,ortho,O
104948,14,and,O
104948,14,found,O
104948,14,to,O
104948,14,be,O
104948,14,floridly,O
104948,14,septic,O
104948,14,.,O
104948,15,He,O
104948,15,was,O
104948,15,taken,O
104948,15,to,O
104948,15,the,O
104948,15,OR,O
104948,15,and,O
104948,15,washed,O
104948,15,out,O
104948,15,by,O
104948,15,Ortho,O
104948,15,(,O
104948,15,please,O
104948,15,see,O
104948,15,seperate,O
104948,15,op,O
104948,15,note,O
104948,15,for,O
104948,15,full,O
104948,15,accounting,O
104948,15,of,O
104948,15,this,O
104948,15,procedure,O
104948,15,),O
104948,15,.,O
104948,15,This,O
104948,15,infection,O
104948,15,was,O
104948,15,found,O
104948,15,to,O
104948,15,be,O
104948,15,MSSA,O
104948,15,",",O
104948,15,which,O
104948,15,also,O
104948,15,grew,O
104948,15,out,O
104948,15,of,O
104948,15,his,O
104948,15,blood,O
104948,15,and,O
104948,15,eventually,O
104948,15,out,O
104948,15,of,O
104948,15,his,O
104948,15,R,O
104948,15,chest,O
104948,15,chemo-port,O
104948,15,",",O
104948,15,which,O
104948,15,was,O
104948,15,removed,O
104948,15,by,O
104948,15,surgery,O
104948,15,.,O
104948,15,He,O
104948,15,was,O
104948,15,maintained,O
104948,15,on,O
104948,15,a,O
104948,15,6week,O
104948,15,course,O
104948,15,of,O
104948,15,Nafcillin,B-Drug
104948,15,for,O
104948,15,this,O
104948,15,staph,B-Reason
104948,15,infection,I-Reason
104948,15,.,O
104948,15,A,O
104948,15,TEE,O
104948,15,demonstrated,O
104948,15,no,O
104948,15,signs,O
104948,15,of,O
104948,15,endocarditis,O
104948,15,.,O
104948,16,Infectious,O
104948,16,disease,O
104948,16,was,O
104948,16,consulted,O
104948,16,and,O
104948,16,assisted,O
104948,16,with,O
104948,16,his,O
104948,16,antibiotic,B-Drug
104948,16,regimen,O
104948,16,.,O
104948,16,The,O
104948,16,patient,O
104948,16,completed,O
104948,16,a,O
104948,16,full,O
104948,16,14d,O
104948,16,course,O
104948,16,of,O
104948,16,Levoflox,B-Drug
104948,16,for,O
104948,16,pneumonia,B-Reason
104948,16,.,O
104948,16,The,O
104948,16,patient,O
104948,16,also,O
104948,16,had,O
104948,16,a,O
104948,16,full,O
104948,16,course,O
104948,16,of,O
104948,16,Clinda,B-Drug
104948,16,for,O
104948,16,a,O
104948,16,question,O
104948,16,of,O
104948,16,toxic,B-Reason
104948,16,shock,I-Reason
104948,16,syndrome,I-Reason
104948,16,or,O
104948,16,aspiration,B-Reason
104948,16,pneumonia,I-Reason
104948,16,.,O
104948,16,His,O
104948,16,Vanco,B-Drug
104948,16,was,O
104948,16,d/c,O
104948,16,'d,O
104948,16,after,O
104948,16,5d,O
104948,16,due,O
104948,16,to,O
104948,16,only,O
104948,16,MSSA,O
104948,16,growing,O
104948,16,out,O
104948,16,.,O
104948,16,On,O
104948,16,[,O
104948,16,*,O
104948,16,*,O
104948,16,12-20,O
104948,16,*,O
104948,16,*,O
104948,16,],O
104948,16,his,O
104948,16,pre-existing,O
104948,16,R,O
104948,16,chest,O
104948,16,chemo,O
104948,16,port,O
104948,16,was,O
104948,16,noted,O
104948,16,to,O
104948,16,be,O
104948,16,purulent,O
104948,16,and,O
104948,16,was,O
104948,16,removed,O
104948,16,by,O
104948,16,surgery,O
104948,16,.,O
104948,17,This,O
104948,17,grew,O
104948,17,out,O
104948,17,MSSA,O
104948,17,.,O
104948,17,Once,O
104948,17,more,O
104948,17,",",O
104948,17,the,O
104948,17,nafcillin,B-Drug
104948,17,was,O
104948,17,continued,O
104948,17,for,O
104948,17,6week,O
104948,17,total,O
104948,17,course,O
104948,17,.,O
104948,17,A,O
104948,17,[,O
104948,17,*,O
104948,17,*,O
104948,17,12-21,O
104948,17,*,O
104948,17,*,O
104948,17,],O
104948,17,culture,O
104948,17,grew,O
104948,17,out,O
104948,17,yeast,B-Reason
104948,17,and,O
104948,17,he,O
104948,17,was,O
104948,17,started,O
104948,17,on,O
104948,17,a,O
104948,17,course,O
104948,17,of,O
104948,17,fluconisol,B-Drug
104948,17,as,O
104948,17,per,O
104948,17,ID,O
104948,17,.,O
104948,17,He,O
104948,17,recieved,O
104948,17,a,O
104948,17,full,O
104948,17,Ophtho,O
104948,17,eval,O
104948,17,which,O
104948,17,demonstrated,O
104948,17,no,O
104948,17,ocular,O
104948,17,involvment,O
104948,17,.,O
104948,17,Planned,O
104948,17,course,O
104948,17,of,O
104948,17,treatment,O
104948,17,is,O
104948,17,for,O
104948,17,nafcillin,B-Drug
104948,17,for,O
104948,17,total,O
104948,17,of,O
104948,17,6,O
104948,17,weeks,O
104948,17,to,O
104948,17,end,O
104948,17,[,O
104948,17,*,O
104948,17,*,O
104948,17,1-30,O
104948,17,*,O
104948,17,*,O
104948,17,],O
104948,17,",",O
104948,17,fluconazole,B-Drug
104948,17,for,O
104948,17,2,O
104948,17,weeks,O
104948,17,total,O
104948,17,to,O
104948,17,end,O
104948,17,[,O
104948,17,*,O
104948,17,*,O
104948,17,1-9,O
104948,17,*,O
104948,17,*,O
104948,17,],O
104948,17,",",O
104948,17,and,O
104948,17,ceftriaxone,B-Drug
104948,17,to,O
104948,17,end,O
104948,17,[,O
104948,17,*,O
104948,17,*,O
104948,17,1-10,O
104948,17,*,O
104948,18,*,O
104948,18,],O
104948,18,.,O
104948,18,.,O
104948,18,#,O
104948,18,Afib,B-Reason
104948,18,c,I-Reason
104948,18,RvR,I-Reason
104948,18,:,O
104948,18,New-onset,O
104948,18,afib,O
104948,18,in,O
104948,18,the,O
104948,18,face,O
104948,18,of,O
104948,18,sepsis,B-Reason
104948,18,",",O
104948,18,hypotension,B-Reason
104948,18,",",O
104948,18,infection,B-Reason
104948,18,.,O
104948,18,Patient,O
104948,18,initially,O
104948,18,controlled,O
104948,18,with,O
104948,18,boluses,O
104948,18,of,O
104948,18,Diltiazem,B-Drug
104948,18,or,O
104948,18,Lopressor,B-Drug
104948,18,.,O
104948,18,Often,O
104948,18,returned,O
104948,18,into,O
104948,18,Afib,B-Reason
104948,18,during,O
104948,18,times,O
104948,18,of,O
104948,18,increased,O
104948,18,activity,O
104948,18,or,O
104948,18,stress,O
104948,18,.,O
104948,18,Used,O
104948,18,neosynepharine,B-Drug
104948,18,which,O
104948,18,seemed,O
104948,18,less,O
104948,18,arrhythmagenic,O
104948,18,.,O
104948,18,Amiodarone,B-Drug
104948,18,was,O
104948,18,tried,O
104948,18,initially,O
104948,18,for,O
104948,18,control,B-Reason
104948,18,",",O
104948,18,but,O
104948,18,the,O
104948,18,patient,O
104948,18,became,O
104948,18,to,O
104948,18,bradycardic,B-ADE
104948,18,on,O
104948,18,this,O
104948,18,[,O
104948,18,*,O
104948,18,*,O
104948,18,Doctor,O
104948,18,Last,O
104948,18,Name,O
104948,18,360,O
104948,18,*,O
104948,18,*,O
104948,18,],O
104948,18,.,O
104948,19,As,O
104948,19,patient,O
104948,19,was,O
104948,19,weaned,O
104948,19,from,O
104948,19,pressors,B-Drug
104948,19,he,O
104948,19,was,O
104948,19,begun,O
104948,19,on,O
104948,19,a,O
104948,19,regimen,O
104948,19,of,O
104948,19,metoprolol,B-Drug
104948,19,which,O
104948,19,seemed,O
104948,19,to,O
104948,19,control,B-Reason
104948,19,his,I-Reason
104948,19,rate,I-Reason
104948,19,well,O
104948,19,.,O
104948,19,He,O
104948,19,did,O
104948,19,ocassionally,O
104948,19,return,O
104948,19,to,O
104948,19,RVR,B-Reason
104948,19,",",O
104948,19,which,O
104948,19,was,O
104948,19,treated,O
104948,19,with,O
104948,19,boluses,O
104948,19,of,O
104948,19,dilt,B-Drug
104948,19,or,O
104948,19,lopressor,B-Drug
104948,19,with,O
104948,19,good,O
104948,19,effect,O
104948,19,.,O
104948,19,He,O
104948,19,was,O
104948,19,then,O
104948,19,restarted,O
104948,19,on,O
104948,19,amiodarone,B-Drug
104948,19,[,O
104948,19,*,O
104948,19,*,O
104948,19,1-1,O
104948,19,*,O
104948,19,*,O
104948,19,],O
104948,19,and,O
104948,19,responded,O
104948,19,to,O
104948,19,it,O
104948,19,well,O
104948,19,.,O
104948,19,Due,O
104948,19,to,O
104948,19,his,O
104948,19,brain,O
104948,19,tumor,O
104948,19,he,O
104948,19,was,O
104948,19,note,O
104948,19,anticoagulated,O
104948,19,during,O
104948,19,his,O
104948,19,time,O
104948,19,in,O
104948,19,the,O
104948,19,ICU,O
104948,19,.,O
104948,20,The,O
104948,20,risks,O
104948,20,and,O
104948,20,benefits,O
104948,20,were,O
104948,20,discussed,O
104948,20,.,O
104948,20,It,O
104948,20,was,O
104948,20,felt,O
104948,20,that,O
104948,20,the,O
104948,20,risks,O
104948,20,of,O
104948,20,ICH,O
104948,20,outweighed,O
104948,20,the,O
104948,20,benefits,O
104948,20,of,O
104948,20,stroke,O
104948,20,prevention,O
104948,20,at,O
104948,20,this,O
104948,20,time,O
104948,20,.,O
104948,20,Plans,O
104948,20,were,O
104948,20,made,O
104948,20,to,O
104948,20,readdress,O
104948,20,this,O
104948,20,issue,O
104948,20,once,O
104948,20,the,O
104948,20,patient,O
104948,20,'s,O
104948,20,mental,O
104948,20,status,O
104948,20,improved,O
104948,20,.,O
104948,20,.,O
104948,20,#,O
104948,20,Septic,B-Reason
104948,20,Arthritis,I-Reason
104948,20,:,O
104948,20,As,O
104948,20,above,O
104948,20,",",O
104948,20,had,O
104948,20,septic,O
104948,20,arthritis,O
104948,20,of,O
104948,20,L,O
104948,20,knee,O
104948,20,treated,O
104948,20,via,O
104948,20,washout,O
104948,20,by,O
104948,20,ortho,O
104948,20,on,O
104948,20,[,O
104948,20,*,O
104948,20,*,O
104948,20,12-17,O
104948,20,*,O
104948,20,*,O
104948,20,],O
104948,20,.,O
104948,20,Nafcillin,B-Drug
104948,20,x6weeks,O
104948,20,per,O
104948,20,ID,O
104948,20,started,O
104948,20,on,O
104948,20,[,O
104948,20,*,O
104948,20,*,O
104948,20,12-19,O
104948,20,*,O
104948,20,*,O
104948,20,],O
104948,20,.,O
104948,21,Nafcillin,B-Drug
104948,21,is,O
104948,21,scheduled,O
104948,21,to,O
104948,21,finish,O
104948,21,on,O
104948,21,[,O
104948,21,*,O
104948,21,*,O
104948,21,1-30,O
104948,21,*,O
104948,21,*,O
104948,21,],O
104948,21,.,O
104948,21,Patient,O
104948,21,did,O
104948,21,have,O
104948,21,a,O
104948,21,swollen,O
104948,21,L,O
104948,21,wrist,O
104948,21,later,O
104948,21,in,O
104948,21,his,O
104948,21,course,O
104948,21,",",O
104948,21,but,O
104948,21,this,O
104948,21,was,O
104948,21,tapped,O
104948,21,by,O
104948,21,Ortho,O
104948,21,and,O
104948,21,never,O
104948,21,grew,O
104948,21,out,O
104948,21,any,O
104948,21,bacteria,O
104948,21,.,O
104948,21,Plastics-hand,O
104948,21,was,O
104948,21,consulted,O
104948,21,and,O
104948,21,felt,O
104948,21,clinically,O
104948,21,that,O
104948,21,this,O
104948,21,was,O
104948,21,not,O
104948,21,a,O
104948,21,septic,O
104948,21,joint,O
104948,21,",",O
104948,21,instead,O
104948,21,just,O
104948,21,a,O
104948,21,manifestation,O
104948,21,of,O
104948,21,his,O
104948,21,chronic,O
104948,21,RA,O
104948,21,.,O
104948,21,Ortho,O
104948,21,also,O
104948,21,felt,O
104948,21,it,O
104948,21,was,O
104948,21,not,O
104948,21,prudent,O
104948,21,to,O
104948,21,washout,O
104948,21,his,O
104948,21,R,O
104948,21,knee,O
104948,21,",",O
104948,21,which,O
104948,21,was,O
104948,21,clinically,O
104948,21,asymptomatic,O
104948,21,during,O
104948,21,his,O
104948,21,ICU,O
104948,21,course,O
104948,21,.,O
104948,22,His,O
104948,22,L,O
104948,22,knee,O
104948,22,healed,O
104948,22,well,O
104948,22,and,O
104948,22,the,O
104948,22,staples,O
104948,22,and,O
104948,22,drain,O
104948,22,were,O
104948,22,removed,O
104948,22,without,O
104948,22,incidence,O
104948,22,.,O
104948,22,He,O
104948,22,has,O
104948,22,been,O
104948,22,signed,O
104948,22,off,O
104948,22,from,O
104948,22,direct,O
104948,22,ortho,O
104948,22,care,O
104948,22,",",O
104948,22,and,O
104948,22,is,O
104948,22,weight-bearing,O
104948,22,as,O
104948,22,tolerated,O
104948,22,at,O
104948,22,time,O
104948,22,of,O
104948,22,ICU,O
104948,22,discharge,O
104948,22,.,O
104948,22,.,O
104948,22,#,O
104948,22,Respiratory,O
104948,22,status,O
104948,22,:,O
104948,22,Patient,O
104948,22,was,O
104948,22,maintained,O
104948,22,on,O
104948,22,ARDS-style,O
104948,22,ventilation,O
104948,22,while,O
104948,22,on,O
104948,22,the,O
104948,22,ventilator,O
104948,22,.,O
104948,22,He,O
104948,22,has,O
104948,22,a,O
104948,22,bronchoscopy,O
104948,22,on,O
104948,22,[,O
104948,22,*,O
104948,22,*,O
104948,22,12-18,O
104948,22,*,O
104948,22,*,O
104948,22,],O
104948,22,which,O
104948,22,showed,O
104948,22,diffuse,O
104948,22,thick,O
104948,22,bloody,O
104948,22,sputum,O
104948,22,greatest,O
104948,22,in,O
104948,22,the,O
104948,22,R,O
104948,22,LL,O
104948,22,.,O
104948,23,By,O
104948,23,[,O
104948,23,*,O
104948,23,*,O
104948,23,12-19,O
104948,23,*,O
104948,23,*,O
104948,23,],O
104948,23,the,O
104948,23,patient,O
104948,23,was,O
104948,23,changed,O
104948,23,to,O
104948,23,pressure,O
104948,23,support,O
104948,23,ventilation,O
104948,23,.,O
104948,23,The,O
104948,23,patient,O
104948,23,was,O
104948,23,activily,O
104948,23,diuresed,O
104948,23,at,O
104948,23,this,O
104948,23,time,O
104948,23,",",O
104948,23,with,O
104948,23,good,O
104948,23,effect,O
104948,23,and,O
104948,23,improving,O
104948,23,respiratory,O
104948,23,status,O
104948,23,.,O
104948,23,The,O
104948,23,patient,O
104948,23,tested,O
104948,23,negative,O
104948,23,for,O
104948,23,legionella,O
104948,23,and,O
104948,23,influenza,O
104948,23,.,O
104948,23,The,O
104948,23,patient,O
104948,23,was,O
104948,23,quickly,O
104948,23,weaned,O
104948,23,to,O
104948,23,CPAP+PS,O
104948,23,of,O
104948,23,[,O
104948,23,*,O
104948,23,*,O
104948,23,4-7,O
104948,23,*,O
104948,23,*,O
104948,23,],O
104948,23,",",O
104948,23,but,O
104948,23,was,O
104948,23,difficult,O
104948,23,to,O
104948,23,wean,O
104948,23,fully,O
104948,23,from,O
104948,23,the,O
104948,23,vent,O
104948,23,due,O
104948,23,mainly,O
104948,23,to,O
104948,23,his,O
104948,23,mental,O
104948,23,status,O
104948,23,.,O
104948,23,He,O
104948,23,was,O
104948,23,extubated,O
104948,23,on,O
104948,23,[,O
104948,23,*,O
104948,23,*,O
104948,23,12-24,O
104948,23,*,O
104948,23,*,O
104948,23,],O
104948,23,with,O
104948,23,great,O
104948,23,success,O
104948,23,.,O
104948,24,On,O
104948,24,[,O
104948,24,*,O
104948,24,*,O
104948,24,12-25,O
104948,24,*,O
104948,24,*,O
104948,24,],O
104948,24,the,O
104948,24,patient,O
104948,24,was,O
104948,24,noted,O
104948,24,to,O
104948,24,have,O
104948,24,an,O
104948,24,increasing,O
104948,24,o2,O
104948,24,requirement,O
104948,24,and,O
104948,24,a,O
104948,24,CXR,O
104948,24,demonstrated,O
104948,24,a,O
104948,24,moderate-sized,O
104948,24,R,O
104948,24,pneumothorax,O
104948,24,.,O
104948,24,Thoracic,O
104948,24,surgery,O
104948,24,was,O
104948,24,consulted,O
104948,24,and,O
104948,24,placed,O
104948,24,a,O
104948,24,chest,O
104948,24,tube,O
104948,24,.,O
104948,24,This,O
104948,24,tube,O
104948,24,was,O
104948,24,intermittantly,O
104948,24,to,O
104948,24,wall-suction,O
104948,24,",",O
104948,24,water-seal,O
104948,24,or,O
104948,24,clamped,O
104948,24,.,O
104948,24,On,O
104948,24,[,O
104948,24,*,O
104948,24,*,O
104948,24,1-2,O
104948,24,*,O
104948,24,*,O
104948,24,],O
104948,24,it,O
104948,24,was,O
104948,24,d/c,O
104948,24,'d,O
104948,24,",",O
104948,24,with,O
104948,24,the,O
104948,24,pneumothoax,O
104948,24,smaller,O
104948,24,in,O
104948,24,size,O
104948,24,.,O
104948,24,.,O
104948,24,#,O
104948,24,GBM,O
104948,24,:,O
104948,24,Head,O
104948,24,CTs,O
104948,24,compared,O
104948,24,to,O
104948,24,his,O
104948,24,baseline,O
104948,24,[,O
104948,24,*,O
104948,24,*,O
104948,24,Hospital1,O
104948,24,2025,O
104948,24,*,O
104948,24,*,O
104948,24,],O
104948,24,scans,O
104948,24,showed,O
104948,24,no,O
104948,24,interval,O
104948,24,change,O
104948,24,.,O
104948,25,He,O
104948,25,was,O
104948,25,maintained,O
104948,25,on,O
104948,25,his,O
104948,25,baseline,O
104948,25,3mg,O
104948,25,of,O
104948,25,Dexamethasone,B-Drug
104948,25,while,O
104948,25,inpatient,O
104948,25,here,O
104948,25,.,O
104948,25,It,O
104948,25,appears,O
104948,25,that,O
104948,25,neurooncs,O
104948,25,original,O
104948,25,plans,O
104948,25,were,O
104948,25,to,O
104948,25,taper,O
104948,25,the,O
104948,25,dexamethasone,B-Drug
104948,25,.,O
104948,25,We,O
104948,25,were,O
104948,25,unable,O
104948,25,to,O
104948,25,contact,O
104948,25,primary,O
104948,25,neuro-oncoligist,O
104948,25,to,O
104948,25,discuss,O
104948,25,steroid,B-Drug
104948,25,taper,O
104948,25,but,O
104948,25,this,O
104948,25,should,O
104948,25,be,O
104948,25,discussed,O
104948,25,with,O
104948,25,Dr.,O
104948,25,[,O
104948,25,*,O
104948,25,*,O
104948,25,Last,O
104948,25,Name,O
104948,25,(,O
104948,25,STitle,O
104948,25,),O
104948,25,*,O
104948,25,*,O
104948,25,],O
104948,25,when,O
104948,25,he,O
104948,25,becomes,O
104948,25,available,O
104948,25,.,O
104948,25,.,O
104948,25,#,O
104948,25,Anemia/thrombocytopenia,O
104948,25,:,O
104948,25,Had,O
104948,25,anemia,O
104948,25,of,O
104948,25,chronic,O
104948,25,disease,O
104948,25,",",O
104948,25,admitted,O
104948,25,with,O
104948,25,thrombocytopenia,B-ADE
104948,25,attributed,O
104948,25,to,O
104948,25,Avastin,B-Drug
104948,25,and,O
104948,25,timador,B-Drug
104948,25,.,O
104948,26,His,O
104948,26,thrombocytopenia,O
104948,26,was,O
104948,26,asymptomatic,O
104948,26,during,O
104948,26,his,O
104948,26,hospital,O
104948,26,course,O
104948,26,",",O
104948,26,and,O
104948,26,steadily,O
104948,26,improved,O
104948,26,.,O
104948,26,His,O
104948,26,anemia,O
104948,26,was,O
104948,26,mild,O
104948,26,",",O
104948,26,and,O
104948,26,did,O
104948,26,require,O
104948,26,occasional,O
104948,26,transfusion,O
104948,26,.,O
104948,26,.,O
104948,26,#,O
104948,26,Hyperglycemia,B-Reason
104948,26,:,O
104948,26,Intitally,O
104948,26,hyperglycemic,O
104948,26,in,O
104948,26,face,O
104948,26,of,O
104948,26,sepsis,O
104948,26,",",O
104948,26,controlled,O
104948,26,with,O
104948,26,SS,O
104948,26,insulin,B-Drug
104948,26,and,O
104948,26,resolved,O
104948,26,on,O
104948,26,its,O
104948,26,own,O
104948,26,.,O
104948,26,.,O
104948,26,#,O
104948,26,R,O
104948,26,Chest,B-Reason
104948,26,wound,I-Reason
104948,26,:,O
104948,26,Co,O
104948,26,n't,O
104948,26,to,O
104948,26,drain,O
104948,26,purulent,O
104948,26,material,O
104948,26,s/p,O
104948,26,removal,O
104948,26,of,O
104948,26,port,O
104948,26,.,O
104948,26,Surgery,O
104948,26,recommended,O
104948,26,QID,O
104948,26,dilute,O
104948,26,(,O
104948,26,[,O
104948,26,*,O
104948,26,*,O
104948,26,12-6,O
104948,26,*,O
104948,26,*,O
104948,26,],O
104948,26,),O
104948,26,Dakin,B-Drug
104948,26,'s,I-Drug
104948,26,solution,I-Drug
104948,26,and,O
104948,26,close,O
104948,26,f/u,O
104948,26,.,O
104948,27,Any,O
104948,27,fluctuant,O
104948,27,areas,O
104948,27,must,O
104948,27,be,O
104948,27,debrided,O
104948,27,.,O
104948,27,.,O
104948,27,#,O
104948,27,Mental,O
104948,27,Status,O
104948,27,:,O
104948,27,The,O
104948,27,patient,O
104948,27,presented,O
104948,27,with,O
104948,27,altered,O
104948,27,mental,O
104948,27,status,O
104948,27,felt,O
104948,27,to,O
104948,27,be,O
104948,27,due,O
104948,27,to,O
104948,27,sepsis,O
104948,27,.,O
104948,27,He,O
104948,27,did,O
104948,27,take,O
104948,27,some,O
104948,27,days,O
104948,27,to,O
104948,27,awaken,O
104948,27,from,O
104948,27,his,O
104948,27,intubated,O
104948,27,and,O
104948,27,sedated,O
104948,27,state,O
104948,27,.,O
104948,27,He,O
104948,27,continued,O
104948,27,to,O
104948,27,be,O
104948,27,Aox1-2,O
104948,27,in,O
104948,27,the,O
104948,27,MICU,O
104948,27,",",O
104948,27,with,O
104948,27,symptoms,O
104948,27,consistent,O
104948,27,with,O
104948,27,delerium,O
104948,27,.,O
104948,27,A,O
104948,27,repeat,O
104948,27,head,O
104948,27,CT,O
104948,27,showed,O
104948,27,no,O
104948,27,change,O
104948,27,;,O
104948,27,his,O
104948,27,delerium,O
104948,27,was,O
104948,27,felt,O
104948,27,to,O
104948,27,be,O
104948,27,mainly,O
104948,27,post-septic,O
104948,27,and,O
104948,27,ICU,O
104948,27,related,O
104948,27,and,O
104948,27,appeared,O
104948,27,to,O
104948,27,be,O
104948,27,slowly,O
104948,27,intervally,O
104948,27,improving,O
104948,27,each,O
104948,27,day,O
104948,27,.,O
104948,28,.,O
104948,28,#,O
104948,28,Prophylaxis,B-Reason
104948,28,:,O
104948,28,Patient,O
104948,28,was,O
104948,28,initially,O
104948,28,on,O
104948,28,pneumoboots,O
104948,28,and,O
104948,28,then,O
104948,28,Heparin,B-Drug
104948,28,SC,O
104948,28,",",O
104948,28,a,O
104948,28,bowel,O
104948,28,regmimen,O
104948,28,and,O
104948,28,a,O
104948,28,Gi,O
104948,28,prophlyaxsis,O
104948,28,throughout,O
104948,28,his,O
104948,28,hospital,O
104948,28,course,O
104948,28,.,O
104948,28,.,O
104948,28,#,O
104948,28,Electrolytes,O
104948,28,:,O
104948,28,The,O
104948,28,patient,O
104948,28,required,O
104948,28,extensive,O
104948,28,repletion,O
104948,28,of,O
104948,28,his,O
104948,28,potassium,O
104948,28,during,O
104948,28,his,O
104948,28,ICU,O
104948,28,course,O
104948,28,",",O
104948,28,often,O
104948,28,requiring,O
104948,28,q6hr,O
104948,28,lyte,O
104948,28,checks,O
104948,28,and,O
104948,28,100-200meq,O
104948,28,of,O
104948,28,K+,O
104948,28,per,O
104948,28,day,O
104948,28,.,O
104948,28,This,O
104948,28,was,O
104948,28,felt,O
104948,28,to,O
104948,28,be,O
104948,28,mostly,O
104948,28,due,O
104948,28,to,O
104948,28,a,O
104948,28,diarrhea,O
104948,28,and,O
104948,28,thus,O
104948,28,GI,O
104948,28,loss,O
104948,28,",",O
104948,28,and,O
104948,28,was,O
104948,28,resolving,O
104948,28,at,O
104948,28,the,O
104948,28,end,O
104948,28,of,O
104948,28,his,O
104948,28,hospital,O
104948,28,course,O
104948,28,as,O
104948,28,diarrhea,O
104948,28,resolved,O
104948,28,.,O
104948,29,.,O
104948,29,#,O
104948,29,Nutrition,O
104948,29,:,O
104948,29,The,O
104948,29,patient,O
104948,29,was,O
104948,29,maintained,O
104948,29,on,O
104948,29,TF,O
104948,29,while,O
104948,29,intubated,O
104948,29,",",O
104948,29,and,O
104948,29,also,O
104948,29,s/p,O
104948,29,intubation,O
104948,29,as,O
104948,29,he,O
104948,29,failed,O
104948,29,his,O
104948,29,initial,O
104948,29,speech,O
104948,29,and,O
104948,29,swallow,O
104948,29,exams,O
104948,29,.,O
104948,29,On,O
104948,29,[,O
104948,29,*,O
104948,29,*,O
104948,29,1-3,O
104948,29,*,O
104948,29,*,O
104948,29,],O
104948,29,he,O
104948,29,passed,O
104948,29,his,O
104948,29,speech,O
104948,29,and,O
104948,29,swallow,O
104948,29,bedside,O
104948,29,test,O
104948,29,.,O
104948,29,.,O
104948,29,#,O
104948,29,LFTs,O
104948,29,:,O
104948,29,Patient,O
104948,29,had,O
104948,29,elevated,O
104948,29,LFTs,O
104948,29,on,O
104948,29,presentation,O
104948,29,which,O
104948,29,were,O
104948,29,attributed,O
104948,29,to,O
104948,29,sepsis,O
104948,29,.,O
104948,29,This,O
104948,29,abnormality,O
104948,29,resolved,O
104948,29,as,O
104948,29,the,O
104948,29,patient,O
104948,29,'s,O
104948,29,clinical,O
104948,29,picture,O
104948,29,improved,O
104948,29,.,O
104948,29,He,O
104948,29,should,O
104948,29,continue,O
104948,29,on,O
104948,29,weekly,O
104948,29,LFT,O
104948,29,checks,O
104948,29,due,O
104948,29,to,O
104948,29,his,O
104948,29,continuing,O
104948,29,nafcillin,B-Drug
104948,29,.,O
104948,30,.,O
104948,30,#,O
104948,30,PT/OT,O
104948,30,:,O
104948,30,after,O
104948,30,extubation,O
104948,30,the,O
104948,30,patient,O
104948,30,was,O
104948,30,followed,O
104948,30,actively,O
104948,30,by,O
104948,30,PT,O
104948,30,and,O
104948,30,OT,O
104948,30,.,O
104948,30,Medications,O
104948,30,on,O
104948,30,Admission,O
104948,30,:,O
104948,30,#,O
104948,30,Naproxen,B-Drug
104948,30,prn,O
104948,30,#,O
104948,30,Mepron,B-Drug
104948,30,(,O
104948,30,prophylaxis,B-Reason
104948,30,),O
104948,30,#,O
104948,30,Hydrocodone,B-Drug
104948,30,#,O
104948,30,Dexamethasone,B-Drug
104948,30,3mg,O
104948,30,#,O
104948,30,Avastin,B-Drug
104948,30,(,O
104948,30,last,O
104948,30,received,O
104948,30,2wks,O
104948,30,ago,O
104948,30,",",O
104948,30,due,O
104948,30,on,O
104948,30,Monday,O
104948,30,[,O
104948,30,*,O
104948,30,*,O
104948,30,2154-12-16,O
104948,30,*,O
104948,30,*,O
104948,30,],O
104948,30,),O
104948,30,#,O
104948,30,Lipid,O
104948,30,lowering,O
104948,30,[,O
104948,30,*,O
104948,30,*,O
104948,30,Doctor,O
104948,30,Last,O
104948,30,Name,O
104948,30,360,O
104948,30,*,O
104948,30,*,O
104948,30,],O
104948,30,(,O
104948,30,wife,O
104948,30,unsure,O
104948,30,of,O
104948,30,name,O
104948,30,),O
104948,30,#,O
104948,30,Timador,B-Drug
104948,30,(,O
104948,30,was,O
104948,30,previously,O
104948,30,on,O
104948,30,this,O
104948,30,",",O
104948,30,but,O
104948,30,was,O
104948,30,stopped,O
104948,30,[,O
104948,30,*,O
104948,30,*,O
104948,30,1-4,O
104948,30,*,O
104948,30,*,O
104948,30,],O
104948,30,to,O
104948,30,thrombocytopenia,B-ADE
104948,30,),O
104948,30,Discharge,O
104948,30,Medications,O
104948,30,:,O
104948,30,1,O
104948,30,.,O
104948,31,Heparin,B-Drug
104948,31,(,I-Drug
104948,31,Porcine,I-Drug
104948,31,),I-Drug
104948,31,"5,000",O
104948,31,unit/mL,O
104948,31,Solution,O
104948,31,Sig,O
104948,31,:,O
104948,31,5000,O
104948,31,(,O
104948,31,5000,O
104948,31,),O
104948,31,units,O
104948,31,Injection,O
104948,31,TID,O
104948,31,(,O
104948,31,3,O
104948,31,times,O
104948,31,a,O
104948,31,day,O
104948,31,),O
104948,31,.,O
104948,31,2,O
104948,31,.,O
104948,31,Senna,B-Drug
104948,31,8.6,O
104948,31,mg,O
104948,31,Tablet,O
104948,31,Sig,O
104948,31,:,O
104948,31,One,O
104948,31,(,O
104948,31,1,O
104948,31,),O
104948,31,Tablet,O
104948,31,PO,O
104948,31,BID,O
104948,31,(,O
104948,31,2,O
104948,31,times,O
104948,31,a,O
104948,31,day,O
104948,31,),O
104948,31,as,O
104948,31,needed,O
104948,31,.,O
104948,31,3,O
104948,31,.,O
104948,31,Docusate,B-Drug
104948,31,Sodium,I-Drug
104948,31,50,O
104948,31,mg/5,O
104948,31,mL,O
104948,31,Liquid,O
104948,31,Sig,O
104948,31,:,O
104948,31,Five,O
104948,31,(,O
104948,31,5,O
104948,31,),O
104948,31,ml,O
104948,31,PO,O
104948,31,BID,O
104948,31,(,O
104948,31,2,O
104948,31,times,O
104948,31,a,O
104948,31,day,O
104948,31,),O
104948,31,.,O
104948,31,4,O
104948,31,.,O
104948,31,Atovaquone,B-Drug
104948,31,750,O
104948,31,mg/5,O
104948,31,mL,O
104948,31,Suspension,O
104948,31,Sig,O
104948,31,:,O
104948,31,Seven,O
104948,31,[,O
104948,31,*,O
104948,31,*,O
104948,31,Age,O
104948,31,over,O
104948,31,90,O
104948,31,1230,O
104948,31,*,O
104948,31,*,O
104948,31,],O
104948,31,y,O
104948,31,(,O
104948,31,750,O
104948,31,),O
104948,31,mg,O
104948,31,PO,O
104948,31,BID,O
104948,31,(,O
104948,31,2,O
104948,32,times,O
104948,32,a,O
104948,32,day,O
104948,32,),O
104948,32,.,O
104948,32,5,O
104948,32,.,O
104948,32,Nystatin,B-Drug
104948,32,"100,000",O
104948,32,unit/mL,O
104948,32,Suspension,O
104948,32,Sig,O
104948,32,:,O
104948,32,Five,O
104948,32,(,O
104948,32,5,O
104948,32,),O
104948,32,ML,O
104948,32,PO,O
104948,32,QID,O
104948,32,(,O
104948,32,4,O
104948,32,times,O
104948,32,a,O
104948,32,day,O
104948,32,),O
104948,32,as,O
104948,32,needed,O
104948,32,.,O
104948,32,6,O
104948,32,.,O
104948,32,Dexamethasone,B-Drug
104948,32,1.5,O
104948,32,mg,O
104948,32,Tablet,O
104948,32,Sig,O
104948,32,:,O
104948,32,Two,O
104948,32,(,O
104948,32,2,O
104948,32,),O
104948,32,Tablet,O
104948,32,PO,O
104948,32,DAILY,O
104948,32,(,O
104948,32,Daily,O
104948,32,),O
104948,32,.,O
104948,32,7,O
104948,32,.,O
104948,32,Acetaminophen,B-Drug
104948,32,325,O
104948,32,mg,O
104948,32,Tablet,O
104948,32,Sig,O
104948,32,:,O
104948,32,1-2,O
104948,32,Tablets,O
104948,32,PO,O
104948,32,Q6H,O
104948,32,(,O
104948,32,every,O
104948,32,6,O
104948,32,hours,O
104948,32,),O
104948,32,as,O
104948,32,needed,O
104948,32,.,O
104948,32,8,O
104948,32,.,O
104948,32,Guaifenesin,B-Drug
104948,32,100,O
104948,32,mg/5,O
104948,32,mL,O
104948,32,Syrup,O
104948,32,Sig,O
104948,32,:,O
104948,32,Fifteen,O
104948,32,(,O
104948,32,15,O
104948,32,),O
104948,32,ML,O
104948,32,PO,O
104948,32,Q6H,O
104948,32,(,O
104948,32,every,O
104948,32,6,O
104948,32,hours,O
104948,32,),O
104948,32,as,O
104948,32,needed,O
104948,32,for,O
104948,32,cough,B-Reason
104948,32,.,O
104948,33,9,O
104948,33,.,O
104948,33,Fluconazole,B-Drug
104948,33,200,O
104948,33,mg,O
104948,33,Tablet,O
104948,33,Sig,O
104948,33,:,O
104948,33,Two,O
104948,33,(,O
104948,33,2,O
104948,33,),O
104948,33,Tablet,O
104948,33,PO,O
104948,33,Q24H,O
104948,33,(,O
104948,33,every,O
104948,33,24,O
104948,33,hours,O
104948,33,),O
104948,33,for,O
104948,33,2,O
104948,33,weeks,O
104948,33,:,O
104948,33,last,O
104948,33,day,O
104948,33,[,O
104948,33,*,O
104948,33,*,O
104948,33,1-9,O
104948,33,*,O
104948,33,*,O
104948,33,],O
104948,33,.,O
104948,33,10,O
104948,33,.,O
104948,33,Metoprolol,B-Drug
104948,33,Tartrate,I-Drug
104948,33,25,O
104948,33,mg,O
104948,33,Tablet,O
104948,33,Sig,O
104948,33,:,O
104948,33,0.5,O
104948,33,Tablet,O
104948,33,PO,O
104948,33,TID,O
104948,33,(,O
104948,33,3,O
104948,33,times,O
104948,33,a,O
104948,33,day,O
104948,33,),O
104948,33,:,O
104948,33,hold,O
104948,33,for,O
104948,33,HR,O
104948,33,<,O
104948,33,50,O
104948,33,and,O
104948,33,SBP,O
104948,33,<,O
104948,33,100,O
104948,33,.,O
104948,33,11,O
104948,33,.,O
104948,33,Amiodarone,B-Drug
104948,33,200,O
104948,33,mg,O
104948,33,Tablet,O
104948,33,Sig,O
104948,33,:,O
104948,33,Two,O
104948,33,(,O
104948,33,2,O
104948,33,),O
104948,33,Tablet,O
104948,33,PO,O
104948,33,BID,O
104948,33,(,O
104948,33,2,O
104948,33,times,O
104948,33,a,O
104948,33,day,O
104948,33,),O
104948,33,:,O
104948,33,[,O
104948,33,*,O
104948,33,*,O
104948,33,Hospital1,O
104948,33,*,O
104948,33,*,O
104948,33,],O
104948,33,until,O
104948,33,[,O
104948,33,*,O
104948,33,*,O
104948,33,1-7,O
104948,33,*,O
104948,33,*,O
104948,34,],O
104948,34,then,O
104948,34,400mg,O
104948,34,daily,O
104948,34,.,O
104948,34,12,O
104948,34,.,O
104948,34,Famotidine,B-Drug
104948,34,10,O
104948,34,mg/mL,O
104948,34,Solution,O
104948,34,Sig,O
104948,34,:,O
104948,34,Twenty,O
104948,34,(,O
104948,34,20,O
104948,34,),O
104948,34,mg,O
104948,34,Intravenous,O
104948,34,Q12H,O
104948,34,(,O
104948,34,every,O
104948,34,12,O
104948,34,hours,O
104948,34,),O
104948,34,.,O
104948,34,13,O
104948,34,.,O
104948,34,Ceftriaxone-Dextrose,B-Drug
104948,34,(,I-Drug
104948,34,Iso-osm,I-Drug
104948,34,),I-Drug
104948,34,1,O
104948,34,gram/50,O
104948,34,mL,O
104948,34,Piggyback,O
104948,34,Sig,O
104948,34,:,O
104948,34,One,O
104948,34,(,O
104948,34,1,O
104948,34,),O
104948,34,gram,O
104948,34,Intravenous,O
104948,34,Q24H,O
104948,34,(,O
104948,34,every,O
104948,34,24,O
104948,34,hours,O
104948,34,),O
104948,34,.,O
104948,34,14,O
104948,34,.,O
104948,34,Nafcillin,B-Drug
104948,34,in,I-Drug
104948,34,D2.4W,I-Drug
104948,34,2,O
104948,34,gram/100,O
104948,34,mL,O
104948,34,Piggyback,O
104948,34,Sig,O
104948,34,:,O
104948,34,Two,O
104948,34,(,O
104948,34,2,O
104948,34,),O
104948,34,grams,O
104948,34,Intravenous,O
104948,34,Q6H,O
104948,34,(,O
104948,34,every,O
104948,34,6,O
104948,34,hours,O
104948,34,),O
104948,34,for,O
104948,34,6,O
104948,34,weeks,O
104948,34,:,O
104948,34,last,O
104948,34,day,O
104948,34,[,O
104948,34,*,O
104948,34,*,O
104948,34,1-30,O
104948,34,*,O
104948,34,*,O
104948,34,],O
104948,34,.,O
104948,35,15,O
104948,35,.,O
104948,35,Heparin,B-Drug
104948,35,Lock,I-Drug
104948,35,Flush,I-Drug
104948,35,(,I-Drug
104948,35,Porcine,I-Drug
104948,35,),I-Drug
104948,35,100,O
104948,35,unit/mL,O
104948,35,Syringe,O
104948,35,Sig,O
104948,35,:,O
104948,35,Two,O
104948,35,(,O
104948,35,2,O
104948,35,),O
104948,35,ML,O
104948,35,Intravenous,O
104948,35,DAILY,O
104948,35,(,O
104948,35,Daily,O
104948,35,),O
104948,35,as,O
104948,35,needed,O
104948,35,.,O
104948,35,16,O
104948,35,.,O
104948,35,Insulin,B-Drug
104948,35,NPH,I-Drug
104948,35,Human,I-Drug
104948,35,Recomb,I-Drug
104948,35,100,O
104948,35,unit/mL,O
104948,35,Cartridge,O
104948,35,Sig,O
104948,35,:,O
104948,35,Five,O
104948,35,(,O
104948,35,5,O
104948,35,),O
104948,35,units,O
104948,35,Subcutaneous,O
104948,35,twice,O
104948,35,a,O
104948,35,day,O
104948,35,.,O
104948,35,17,O
104948,35,.,O
104948,35,Insulin,B-Drug
104948,35,Regular,I-Drug
104948,35,Human,I-Drug
104948,35,300,O
104948,35,unit/3,O
104948,35,mL,O
104948,35,Insulin,B-Drug
104948,35,Pen,O
104948,35,Sig,O
104948,35,:,O
104948,35,sliding,O
104948,35,scale,O
104948,35,Subcutaneous,O
104948,35,four,O
104948,35,times,O
104948,35,a,O
104948,35,day,O
104948,35,:,O
104948,35,sliding,O
104948,35,scale,O
104948,35,.,O
104948,35,Discharge,O
104948,35,Disposition,O
104948,35,:,O
104948,35,Extended,O
104948,35,Care,O
104948,35,Facility,O
104948,35,:,O
104948,35,[,O
104948,35,*,O
104948,35,*,O
104948,35,Hospital3,O
104948,35,7,O
104948,35,*,O
104948,35,*,O
104948,35,],O
104948,35,&,O
104948,35,Rehab,O
104948,35,Center,O
104948,35,-,O
104948,35,[,O
104948,35,*,O
104948,35,*,O
104948,35,Hospital1,O
104948,35,8,O
104948,35,*,O
104948,35,*,O
104948,35,],O
104948,35,Discharge,O
104948,35,Diagnosis,O
104948,35,:,O
104948,36,Primary,O
104948,36,:,O
104948,36,Septic,O
104948,36,Shock,O
104948,36,Community,O
104948,36,Aquired,O
104948,36,Pneumonia,O
104948,36,Respiratory,O
104948,36,Failure,O
104948,36,Acute,O
104948,36,Renal,O
104948,36,Failure,O
104948,36,Septic,O
104948,36,Arthritis,O
104948,36,(,O
104948,36,L,O
104948,36,Knee,O
104948,36,),O
104948,36,Bacteremia,O
104948,36,Infected,O
104948,36,R,O
104948,36,Chest,O
104948,36,Catheter,O
104948,36,Afib,O
104948,36,with,O
104948,36,RVR,O
104948,36,Delerium,O
104948,36,Anemia,O
104948,36,Thrombocytopenia,O
104948,36,Hyperglycemia,O
104948,36,Pneumothorax,O
104948,36,(,O
104948,36,R,O
104948,36,),O
104948,36,Hypokalemia,O
104948,36,Transaminitis,O
104948,36,Secondary,O
104948,36,:,O
104948,36,#,O
104948,36,Grade,O
104948,36,4,O
104948,36,glioblastoma,O
104948,36,multiforme,O
104948,36,left,O
104948,36,temporal,O
104948,36,lobe,O
104948,36,;,O
104948,36,s/p,O
104948,36,high,O
104948,36,dose,O
104948,36,radiotherapy,O
104948,36,",",O
104948,36,previously,O
104948,36,on,O
104948,36,high,O
104948,36,dose,O
104948,36,steroids,B-Drug
104948,36,",",O
104948,36,recently,O
104948,36,tapered,O
104948,36,.,O
104948,36,Recently,O
104948,36,placed,O
104948,36,Portacath,O
104948,36,with,O
104948,36,steristrips,O
104948,36,still,O
104948,36,present,O
104948,36,.,O
104948,36,#,O
104948,36,Rheumatoid,B-Reason
104948,36,arthritis,I-Reason
104948,36,;,O
104948,36,on,O
104948,36,remicade,B-Drug
104948,36,until,O
104948,36,recently,O
104948,36,#,O
104948,36,L,O
104948,36,knee,O
104948,36,bursitis,O
104948,36,#,O
104948,36,Hyperlipidemia,O
104948,36,Discharge,O
104948,36,Condition,O
104948,36,:,O
104948,36,fair,O
104948,36,-,O
104948,36,multifactorial,O
104948,36,delirium,O
104948,36,with,O
104948,36,waxing,O
104948,36,and,O
104948,36,[,O
104948,36,*,O
104948,36,*,O
104948,36,Doctor,O
104948,36,Last,O
104948,36,Name,O
104948,36,688,O
104948,37,*,O
104948,37,*,O
104948,37,],O
104948,37,mental,O
104948,37,status,O
104948,37,A+Ox1-2,O
104948,37,Discharge,O
104948,37,Instructions,O
104948,37,:,O
104948,37,You,O
104948,37,were,O
104948,37,admitted,O
104948,37,for,O
104948,37,pneumonia,B-Reason
104948,37,and,O
104948,37,multiple,B-Reason
104948,37,infections,I-Reason
104948,37,including,O
104948,37,of,O
104948,37,your,O
104948,37,knee,O
104948,37,and,O
104948,37,blood,O
104948,37,stream,O
104948,37,.,O
104948,37,you,O
104948,37,were,O
104948,37,treated,O
104948,37,with,O
104948,37,several,O
104948,37,antibiotics,B-Drug
104948,37,and,O
104948,37,had,O
104948,37,a,O
104948,37,stay,O
104948,37,in,O
104948,37,the,O
104948,37,intensive,O
104948,37,care,O
104948,37,unit,O
104948,37,which,O
104948,37,required,O
104948,37,intubation,O
104948,37,.,O
104948,37,Currently,O
104948,37,you,O
104948,37,are,O
104948,37,being,O
104948,37,treated,O
104948,37,for,O
104948,37,these,O
104948,37,infections,O
104948,37,and,O
104948,37,are,O
104948,37,on,O
104948,37,tube,O
104948,37,feedings,O
104948,37,and,O
104948,37,slowly,O
104948,37,eating,O
104948,37,again,O
104948,37,.,O
104948,37,Regarding,O
104948,37,your,O
104948,37,brain,O
104948,37,tumor,O
104948,37,",",O
104948,37,we,O
104948,37,felt,O
104948,37,that,O
104948,37,this,O
104948,37,issue,O
104948,37,",",O
104948,37,while,O
104948,37,serious,O
104948,37,",",O
104948,37,was,O
104948,37,stable,O
104948,37,during,O
104948,37,your,O
104948,37,stay,O
104948,37,here,O
104948,37,.,O
104948,38,It,O
104948,38,is,O
104948,38,very,O
104948,38,important,O
104948,38,that,O
104948,38,you,O
104948,38,followup,O
104948,38,with,O
104948,38,your,O
104948,38,neuro-oncologist,O
104948,38,Dr.,O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,Last,O
104948,38,Name,O
104948,38,(,O
104948,38,STitle,O
104948,38,),O
104948,38,*,O
104948,38,*,O
104948,38,],O
104948,38,at,O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,Hospital1,O
104948,38,2025,O
104948,38,*,O
104948,38,*,O
104948,38,],O
104948,38,.,O
104948,38,You,O
104948,38,need,O
104948,38,to,O
104948,38,discuss,O
104948,38,with,O
104948,38,him,O
104948,38,whether,O
104948,38,you,O
104948,38,should,O
104948,38,be,O
104948,38,on,O
104948,38,blood,B-Drug
104948,38,thinners,I-Drug
104948,38,.,O
104948,38,.,O
104948,38,Followup,O
104948,38,Instructions,O
104948,38,:,O
104948,38,f/u,O
104948,38,with,O
104948,38,Dr.,O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,First,O
104948,38,Name11,O
104948,38,(,O
104948,38,Name,O
104948,38,Pattern1,O
104948,38,),O
104948,38,*,O
104948,38,*,O
104948,38,],O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,Initial,O
104948,38,(,O
104948,38,NamePattern1,O
104948,38,),O
104948,38,*,O
104948,38,*,O
104948,38,],O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,Last,O
104948,38,Name,O
104948,38,(,O
104948,38,NamePattern1,O
104948,38,),O
104948,38,1005,O
104948,38,*,O
104948,38,*,O
104948,38,],O
104948,38,of,O
104948,38,orthopedic,O
104948,38,surgery,O
104948,38,at,O
104948,38,(,O
104948,38,[,O
104948,38,*,O
104948,38,*,O
104948,38,Telephone/Fax,O
104948,38,(,O
104948,38,1,O
104948,38,),O
104948,38,15940,O
104948,39,*,O
104948,39,*,O
104948,39,],O
104948,39,to,O
104948,39,schedule,O
104948,39,a,O
104948,39,followup,O
104948,39,appointment,O
104948,39,in,O
104948,39,1,O
104948,39,month,O
104948,39,.,O
104948,39,f/u,O
104948,39,with,O
104948,39,your,O
104948,39,outpatient,O
104948,39,rheumatologist,O
104948,39,in,O
104948,39,[,O
104948,39,*,O
104948,39,*,O
104948,39,1-6,O
104948,39,*,O
104948,39,*,O
104948,39,],O
104948,39,weeks,O
104948,39,.,O
104948,39,f/u,O
104948,39,with,O
104948,39,your,O
104948,39,outpatient,O
104948,39,neurooncologist,O
104948,39,Dr.,O
104948,39,[,O
104948,39,*,O
104948,39,*,O
104948,39,Last,O
104948,39,Name,O
104948,39,(,O
104948,39,STitle,O
104948,39,),O
104948,39,*,O
104948,39,*,O
104948,39,],O
104948,39,on,O
104948,39,Monday,O
104948,39,by,O
104948,39,phone,O
104948,39,-,O
104948,39,he,O
104948,39,should,O
104948,39,be,O
104948,39,involved,O
104948,39,in,O
104948,39,deciding,O
104948,39,steroid,O
104948,39,taper,O
104948,39,and,O
104948,39,deciding,O
104948,39,about,O
104948,39,anticoagulation,O
104948,39,.,O
104948,39,Some,O
104948,39,of,O
104948,39,your,O
104948,39,labs,O
104948,39,will,O
104948,39,be,O
104948,39,faxed,O
104948,39,to,O
104948,39,Dr.,O
104948,39,[,O
104948,39,*,O
104948,39,*,O
104948,39,First,O
104948,39,Name4,O
104948,39,(,O
104948,39,NamePattern1,O
104948,39,),O
104948,39,*,O
104948,39,*,O
104948,39,],O
104948,39,[,O
104948,39,*,O
104948,39,*,O
104948,39,Last,O
104948,39,Name,O
104948,39,(,O
104948,39,NamePattern1,O
104948,39,),O
104948,39,*,O
104948,39,*,O
104948,39,],O
104948,39,of,O
104948,39,infectious,O
104948,39,disease,O
104948,39,at,O
104948,39,(,O
104948,39,[,O
104948,39,*,O
104948,40,*,O
104948,40,Telephone/Fax,O
104948,40,(,O
104948,40,1,O
104948,40,),O
104948,40,1353,O
104948,40,*,O
104948,40,*,O
104948,40,],O
104948,40,(,O
104948,40,phone,O
104948,40,(,O
104948,40,[,O
104948,40,*,O
104948,40,*,O
104948,40,Telephone/Fax,O
104948,40,(,O
104948,40,1,O
104948,40,),O
104948,40,17490,O
104948,40,*,O
104948,40,*,O
104948,40,],O
104948,40,),O
104948,40,",",O
104948,40,she,O
104948,40,will,O
104948,40,contact,O
104948,40,you,O
104948,40,regarding,O
104948,40,followup,O
104948,40,.,O
